by Jianping Guo, Abhishek A

Slides:



Advertisements
Similar presentations
Volume 13, Issue 2, Pages (February 2011)
Advertisements

Volume 11, Issue 4, Pages (April 2007)
Volume 16, Issue 6, Pages (August 2016)
Volume 11, Issue 2, Pages (April 2015)
Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Volume 19, Issue 12, Pages (December 2017)
Volume 25, Issue 6, Pages (December 2006)
Volume 33, Issue 2, Pages (January 2009)
Volume 15, Issue 19, Pages (October 2005)
Volume 21, Issue 7, Pages (November 2017)
Volume 21, Issue 5, Pages (October 2017)
Volume 142, Issue 3, Pages (March 2012)
Volume 145, Issue 5, Pages (May 2011)
Volume 12, Issue 8, Pages (August 2015)
Volume 18, Issue 17, Pages (September 2008)
Volume 13, Issue 7, Pages (November 2015)
Joseph T. Rodgers, Rutger O. Vogel, Pere Puigserver  Molecular Cell 
A Rac-cGMP Signaling Pathway
NRP2 represses IGF-IR expression and signaling.
Deubiquitination and Activation of AMPK by USP10
J. Zhu, N. Sun, L. Aoudjit, H. Li, H. Kawachi, S. Lemay, T. Takano 
p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway
APCFZR1 promotes BRAF ubiquitination in a D-box–dependent manner.
Volume 68, Issue 2, Pages e6 (October 2017)
Volume 15, Issue 4, Pages (April 2016)
PKA phosphorylates Thr63 and Ser692 to increase HIF-1α stability.
Volume 19, Issue 2, Pages (April 2017)
Volume 23, Issue 5, Pages (May 2013)
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
Volume 69, Issue 2, Pages e5 (January 2018)
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 26, Issue 6, Pages (September 2013)
Volume 26, Issue 2, Pages (August 2014)
PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD, leading to mTORC2 activation. PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD,
Volume 12, Issue 4, Pages (July 2015)
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
FAK-Mediated Src Phosphorylation of Endophilin A2 Inhibits Endocytosis of MT1-MMP and Promotes ECM Degradation  Xiaoyang Wu, Boyi Gan, Youngdong Yoo,
Volume 59, Issue 6, Pages (September 2015)
Volume 14, Issue 1, Pages (July 2008)
Volume 20, Issue 9, Pages (August 2017)
Volume 18, Issue 12, Pages (March 2017)
Volume 20, Issue 3, Pages (July 2017)
Role of HER2 in mediating acquired resistance to EGFR inhibition.
Volume 28, Issue 1, Pages (October 2007)
Volume 18, Issue 2, Pages (August 2010)
Volume 52, Issue 2, Pages (October 2013)
Disruption of the Rag-Ragulator Complex by c17orf59 Inhibits mTORC1
Fan Yang, Huafeng Zhang, Yide Mei, Mian Wu  Molecular Cell 
Volume 33, Issue 5, Pages (November 2010)
eIF5A-PEAK1 signaling regulates KRAS protein expression.
AMPK directly increases mTORC2 catalytic activity.
Volume 46, Issue 6, Pages (June 2012)
Volume 26, Issue 11, Pages e4 (March 2019)
The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase
Volume 13, Issue 3, Pages (February 2004)
PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359
Kristin K. Brown, Laleh Montaser-Kouhsari, Andrew H. Beck, Alex Toker 
Volume 16, Issue 5, Pages (May 2009)
by Emilie Clement, Hiroyuki Inuzuka, Naoe T
Phosphorylation and Functional Inactivation of TSC2 by Erk
Volume 44, Issue 2, Pages (October 2011)
Volume 1, Issue 3, Pages (April 2002)
by Naoe T. Nihira, Kohei Ogura, Kouhei Shimizu, Brian J
SAP102 Mediates Synaptic Clearance of NMDA Receptors
FIH hydroxylates G9a and GLP at asparagine residues.
Volume 31, Issue 5, Pages (September 2008)
Volume 58, Issue 3, Pages (May 2015)
NSD2-mediated methylation of PTEN at K349 dictates cellular sensitivity to DNA-damaging agents. NSD2-mediated methylation of PTEN at K349 dictates cellular.
Volume 9, Issue 2, Pages (October 2014)
Expression of PKM2 Y105F mutant in H1299 cells leads to decreased proliferation under hypoxic conditions, increased oxidative phosphorylation and reduced.
Presentation transcript:

pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner by Jianping Guo, Abhishek A. Chakraborty, Pengda Liu, Wenjian Gan, Xingnan Zheng, Hiroyuki Inuzuka, Bin Wang, Jinfang Zhang, Linli Zhang, Min Yuan, Jesse Novak, Jin Q. Cheng, Alex Toker, Sabina Signoretti, Qing Zhang, John M. Asara, William G. Kaelin, and Wenyi Wei Science Volume 353(6302):929-932 August 26, 2016 Copyright © 2016, American Association for the Advancement of Science

Fig. 1 pVHL suppresses Akt phosphorylation. pVHL suppresses Akt phosphorylation. (A) Immunoblot (IB) analysis of whole-cell lysates (WCL) derived from VHLf/f MEFs infected with Cre or control (EV) lentivirus. (B) IB analysis of WCL derived from RCC4 or 786-O cells infected with EV or VHL retrovirus. (C and D) 786-O cells were engineered via retroviral infection to stably express pVHL and harvested for hemagglutinin-immunoprecipitation (HA-IP) or IB analysis after culturing under normoxia or hypoxia (1% O2) condition for 16 hours. Jianping Guo et al. Science 2016;353:929-932 Copyright © 2016, American Association for the Advancement of Science

Fig. 2 EglN1 mediates the inhibition of Akt by pVHL. EglN1 mediates the inhibition of Akt by pVHL. (A and C) IB analysis of WCL derived from HEK293 cells (A) infected with different short hairpin RNA (shRNA) lentiviruses, and then (C) treated with or without DMOG (200 μM) for 12 hours before harvesting. (B) IB analysis of EglN1−/− MEFs infected with retroviruses encoding WT or catalytic-inactive (P317R) mutant form of EglN1. (D) IB analysis of WCL derived from 786-O-pVHL and EV cells lentivirally infected with Scramble (sh-Src) or EglN1 shRNAs. (E and F) IB analysis of IP and WCL derived from HEK293 cells transfected with indicated constructs. (E) The cells were serum-starved for 24 hours and then stimulated with insulin (0.1 μM) before harvesting. The relative intensities of EglN1 and pVHL immunoprecipitated by Akt1 in (E) are quantified in (F). Jianping Guo et al. Science 2016;353:929-932 Copyright © 2016, American Association for the Advancement of Science

Fig. 3 EglN1 hydroxylates Akt1 at the Pro125 and Pro313 residues to trigger Akt1 interaction with pVHL. EglN1 hydroxylates Akt1 at the Pro125 and Pro313 residues to trigger Akt1 interaction with pVHL. (A) A schematic illustration of Akt1 domain structures with four putative prolyl-hydroxylation residues identified by means of LC-MS/MS analysis. (B and C) IB analysis of co-immunoprecipitation and WCL derived from HEK293 cells transfected with Flag-pVHL and indicated HA-Akt1 constructs. (D) A schematic representation of the various biotinylated synthetic peptides used in this study. FOXO-like and HIF-ODD–like motifs were labeled in red and green, respectively. (E) Indicated peptides as denoted in (D) were incubated with WCL derived from HEK293 cells transfected with indicated constructs, and precipitated with streptavidin. (F) IB analysis of WCL derived from HEK293 cells transfected with indicated constructs. Where indicated, hypoxia mimetic reagents were used before harvesting for IB analysis. (G) IB analysis of WCL derived from WT or EglN1−/− MEFs infected with a retrovirus encoding Flag-tagged WT-EglN1. (H) In vitro hydroxylation assays with recombinant His-EglN1 and various Akt1 peptides were analyzed by means of dot immunoblot. Jianping Guo et al. Science 2016;353:929-932 Copyright © 2016, American Association for the Advancement of Science

Fig. 4 Disruption of Akt proline-hydroxylation events leads to a sustained Akt kinase activation and increased colony formation and tumor growth. Disruption of Akt proline-hydroxylation events leads to a sustained Akt kinase activation and increased colony formation and tumor growth. (A to C) IB analysis of WCL derived from DLD1-AKT1/2−/− cells (A) infected with lentiviruses encoding WT- or P125/313A-Akt1. (B) Cells were deprived of serum for 24 hours followed by stimulation with insulin (0.1 μM), and relative pT308-Akt intensity was quantified in (C). (D to G) Colony formation (D) and soft agar (F) assays were performed with DLD1-AKT1/2−/− cells generated in (A), and were quantified in (E) and (G) (mean ± SD, n = 3 wells per group). *P < 0.05 (Student’s t test). (H and I) Mouse xenograft experiments were performed with the cells generated in (A). Tumor growth curve (H) and tumor weight (I) were calculated (mean ± SD, n = 6 mice per group). *P < 0.05 (one-way analysis of variance test). (J) A schematic representation of cancer patient-associated Akt mutations. (K and L) Glutathione S-transferase pull-down and IP analysis of WCL derived from HEK293 cells transfected with indicated constructs. (M and N) Relative colony numbers were quantified for colony formation (M) and soft agar (N) assays (mean ± SD, n = 3 wells per group). *P < 0.05, **P < 0.01 (Student’s t test). Jianping Guo et al. Science 2016;353:929-932 Copyright © 2016, American Association for the Advancement of Science